Scientists from UC Davis Center for Surgical Bioengineering, the MIND Institute and UC Berkeley’s Murthy Lab are developing ...

GlobalData is the parent company of Clinical Trials Arena. "Ocugen sets sights on Phase III after GA gene therapy win" was ...

Two of Opus's seven gene therapy assets are in clinical trials, with additional programs expected to enter the clinic.

A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...

The company has made more than 50 deals for its proprietary technology as it looks forward to a potentially “transformative” ...

Clinical and commercial quality controls are eased as the FDA looks to expedite therapy approvals in areas of unmet need.

The FDA granted fast track status to VectorY’s VTx-002, an antibody gene therapy targeting TDP-43 protein aggregates in ALS.

Taysha Gene Therapies Inc. (NASDAQ:TSHA) is one of the best penny stocks to buy for 2026. On January 6, the company confirmed ...

The new method is designed to focus specifically on pain-related signals, without interfering with normal activity in other ...

Orphan Drug Designation applies to approximately 50,000 Patients who predominantly suffer from severe chronic pain due to ...

Osteoarthritis is a highly prevalent joint disease that leads to cartilage breakdown, pain and disability, yet there are ...

For those born with certain types of congenital deafness, the cochlear implant has been a positive and enabling technology.